Downplaying Drug Toxicity in Oncology Clinical Trials Downplaying Drug Toxicity in Oncology Clinical Trials

Incomplete reporting that downplayed drug-related adverse events was identified in 43% of reports of cancer drug trials published by top medical journals.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news